Christian Ehmann
Stock Analyst at Berenberg Bank
(0.66)
# 4,180
Out of 5,020 analysts
193
Total ratings
41.3%
Success rate
-2.8%
Average return
Main Sectors:
Stocks Rated by Christian Ehmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: EVT Evotec SE | Reiterated: Hold | €3.60 | €3.13 | +14.94% | 40 | Sep 25, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Hold | €24.00 | €28.26 | -15.07% | 15 | Sep 3, 2026 | |
| ETR: EUZ Eckert & Ziegler SE | Reiterated: Buy | €23.00 | €12.64 | +81.96% | 1 | Aug 26, 2026 | |
| ETR: FYB Formycon AG | Reiterated: Buy | €40.00 → €30.00 | €19.28 | +55.60% | 15 | Aug 26, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Buy | €24.00 → €27.00 | €23.55 | +14.65% | 8 | Aug 14, 2026 | |
| SWX: KURN Kuros Biosciences AG | Initiated Coverage: Buy | CHF 32.00 | CHF 18.48 | +73.16% | 1 | Jul 7, 2026 | |
| ETR: DMP Dermapharm Holding SE | Reiterated: Hold | €41.00 | €38.55 | n/a | 4 | Aug 26, 2025 | |
| ETR: DRW3 Drägerwerk AG & Co. KGaA | Reiterated: Buy | €85.00 | €119.60 | n/a | 21 | Jul 14, 2025 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €47.00 | €44.42 | n/a | 23 | May 7, 2025 | |
| ETR: M12 M1 Kliniken AG | Reiterated: Buy | €26.00 → €28.00 | €20.50 | n/a | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €43.00 | €39.75 | n/a | 20 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.80 → €5.90 | €2.76 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €5.60 | €2.97 | n/a | 1 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.50 → €17.90 | €0.87 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €30.00 → €33.00 | €12.80 | n/a | 10 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €41.00 → €56.00 | €1.07 | n/a | 2 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €4.20 → €3.50 | €0.01 | n/a | 3 | May 5, 2022 |
Evotec SE
Sep 25, 2026
Reiterated: Hold
Price Target: €3.60
Current: €3.13
Upside: +14.94%
Gerresheimer AG
Sep 3, 2026
Reiterated: Hold
Price Target: €24.00
Current: €28.26
Upside: -15.07%
Eckert & Ziegler SE
Aug 26, 2026
Reiterated: Buy
Price Target: €23.00
Current: €12.64
Upside: +81.96%
Formycon AG
Aug 26, 2026
Reiterated: Buy
Price Target: €40.00 → €30.00
Current: €19.28
Upside: +55.60%
SCHOTT Pharma AG & Co. KGaA
Aug 14, 2026
Reiterated: Buy
Price Target: €24.00 → €27.00
Current: €23.55
Upside: +14.65%
Kuros Biosciences AG
Jul 7, 2026
Initiated Coverage: Buy
Price Target: CHF 32.00
Current: CHF 18.48
Upside: +73.16%
Dermapharm Holding SE
Aug 26, 2025
Reiterated: Hold
Price Target: €41.00
Current: €38.55
Upside: n/a
Drägerwerk AG & Co. KGaA
Jul 14, 2025
Reiterated: Buy
Price Target: €85.00
Current: €119.60
Upside: n/a
Fresenius SE & Co. KGaA
May 7, 2025
Reiterated: Buy
Price Target: €47.00
Current: €44.42
Upside: n/a
M1 Kliniken AG
May 6, 2025
Reiterated: Buy
Price Target: €26.00 → €28.00
Current: €20.50
Upside: n/a
Feb 25, 2025
Reiterated: Hold
Price Target: €43.00
Current: €39.75
Upside: n/a
Nov 11, 2024
Reiterated: Buy
Price Target: €12.80 → €5.90
Current: €2.76
Upside: n/a
Feb 7, 2024
Reiterated: Hold
Price Target: €5.60
Current: €2.97
Upside: n/a
Dec 14, 2023
Reiterated: Buy
Price Target: €16.50 → €17.90
Current: €0.87
Upside: n/a
Nov 21, 2023
Reiterated: Buy
Price Target: €30.00 → €33.00
Current: €12.80
Upside: n/a
May 30, 2023
Reiterated: Buy
Price Target: €41.00 → €56.00
Current: €1.07
Upside: n/a
May 5, 2022
Reiterated: Buy
Price Target: €4.20 → €3.50
Current: €0.01
Upside: n/a